The groundbreaking citizen science app Sea Hero Quest is now available for studies of cognition and spatial navigation
New research has found no link between hormone replacement therapy and dementia risk, however those receiving oestrogen-progesterone therapy for over five years were found to have a small increased risk of Alzheimer’s disease. The BMJ have published the research today (Wednesday 29 September). What is HRT? Hormone replacement therapy (HRT) is commonly offered to help…
New research that patients with Alzheimer’s disease taking a class of drugs known as gliptins have lower levels of the hallmark Alzheimer’s protein in their brains. They also had better scores on memory and thinking tests years after the beginning of the study compared to those not on the drug or those who didn’t have diabetes.
Research links the cocktail party problem with an increased risk of dementia in a study conducted at the University of Oxford. Alzheimer’s Research UK comments on the findings.
Researchers at the UK Dementia Research Institute find that the contents are the gut are important for the creation of new brain cells.
Today is a historic day for dementia research with the US Food and Drug Administration (FDA) announcing the first (conditional) licence of a new drug for Alzheimer’s disease in a generation.
Researchers at the University of Oxford are investigating how iron levels can be used as a marker for dementia.
Researchers at Cardiff University will use stem cell technology to understand how risk genes for Alzheimer’s disease impact how cells in the brain function.
Dr Jonathan Blackman at the University of Bristol is investigating how the Parkinson’s drug, Levodopa may improve sleep and memory in people with mild Alzheimer’s disease.
Research at University College London will investigate how past medical procedures may have transmitted proteins that build up in blood vessels in the brain and cause dementia.